# Salvia miltiorrhiza polysaccharide-Mn²⁺-PLGA as an adjuvant in H9N2 vaccine: Immunomodulatory effects in chickens

**Authors:** Yixuan Zhu, Pengfei Gu, Yongzhan Bao, Bowen Song, Jinglu Zhang, Xiao Wang, Wanyu Shi

PMC · DOI: 10.1016/j.psj.2025.105599 · Poultry Science · 2025-07-26

## TL;DR

A new adjuvant made from Salvia miltiorrhiza polysaccharide and Mn²⁺ improves H9N2 vaccine effectiveness in chickens by boosting immune responses.

## Contribution

MS-PLGA is shown to be an effective adjuvant for H9N2 vaccine in chickens, inducing strong and balanced immune responses.

## Key findings

- MS-PLGA-H9N2 increases specific IgG antibody and HI titers in chickens.
- MS-PLGA activates CD4+ and CD8+ T cells and increases IFN-γ, IL-6, and IFN-β levels.
- Multi-omics analysis shows enhanced immune and defense responses in spleen lymphocytes.

## Abstract

H9N2 is an increasing threat to global poultry production and human health. Vaccination of poultry is a key element of disease control in endemic countries, but the inactivated H9N2 vaccine needs to be used with adjuvants to compensate for its weak immunogenicity. Salvia miltiorrhiza polysaccharide (SMP) and Mn2+ have received extensive attention because of their ability to enhance adaptive immunity and stimulate IFN-β secretion, respectively. Our previous studies had indicated that Mn2+/SMP encapsulated by PLGA (MS-PLGA) can be used as an effective adjuvant for the model antigen (ovalbumin), triggering a potent and durable immune response in mice. Here, we due to confirm the effect of MS-PLGA in chickens. we successfully prepared MS-PLGA-H9N2 and after immunization, it generated stronger specific IgG antibody and higher HI titers, and it also can activate CD4+ and CD8+T cells in peripheral blood and spleen. Moreover, both concentrations of the serum cytokine IFN-γ (Th1), IL-6 (Th2) and IFN-β are increased, demonstrating Th1/Th2 without bias. To elucidate the regulatory mechanism of MS-PLGA-H9N2, multi-omics analysis and immunofluorescence of the spleen were explored. The GO and KEGG pathways revealed that immune response and defense response were promoted and lymphocytes of spleen were activated. Overall, MS-PLGA-H9N2 has the potential to be clinically induce to induce potent immune responses in chickens.

## Linked entities

- **Chemicals:** PLGA (PubChem CID 36797), IL-6 (PubChem CID 165368475)
- **Species:** Gallus gallus (taxon 9031), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 395337] {aka CHIL-6, IL-6, interleukin-6}, IFNW1 (interferon omega 1) [NCBI Gene 554219] {aka IFN-beta, IFN2, IFNB, IFN_B}, OVAL (ovalbumin (SERPINB14)) [NCBI Gene 396058] {aka OVA, SERPINB14}, CD4 (CD4 molecule) [NCBI Gene 395362], INFG (interferon gamma) [NCBI Gene 396054] {aka IFNG}, CD8A (CD8A molecule) [NCBI Gene 403158] {aka CD8, CD8-alpha}
- **Chemicals:** Mn2+ (-), PLGA (MESH:D000077182)
- **Species:** Homo sapiens (human, species) [taxon 9606], H9N2 subtype (serotype) [taxon 102796], Gallus gallus (bantam, species) [taxon 9031], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12341616/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12341616/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12341616/full.md

---
Source: https://tomesphere.com/paper/PMC12341616